Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Howard Baron

Pediatric Gastroenterology Las Vegas, NV Medical Doctor

NPI 1497739601 CMS profile 917965

3196 S Maryland Pkwy, Suite 309, Las Vegas, NV 89109

Open in the dashboard

General payments

$2,810

104 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,500 paid to institutions, not to them · program years 2022–2023

Through program year 2025, Howard Baron of Las Vegas, NV is reported in the CMS Open Payments database as having received $2,810 across 104 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 78th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $395 19
2024 General $609 16
2023 General $742 25
2022 General $471 16
2021 General $197 9
2020 General $155 9
2019 General $241 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Howard Baron
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Howard Baron were reported at $395. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Howard Baron Pediatric Gastroenterology median Middle half National median
2019 $241 $131 $41–$311 $163
2020 $155 $79 $23–$223 $114
2021 $197 $104 $32–$321 $132
2022 $471 $125 $37–$331 $149
2023 $742 $169 $55–$440 $160
2024 $609 $196 $73–$563 $164
2025 $395 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Biotech, Inc. $430 20 payments
  2. Genzyme Corporation $332 17 payments
  3. Mirum Pharmaceuticals, Inc. $329 5 payments
  4. Regeneron Healthcare Solutions, Inc. $307 3 payments
  5. QOL Medical, LLC $234 12 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $214 9 payments
  7. Retrophin, Inc. $191 11 payments
  8. AbbVie, Inc. $142 6 payments
  9. Alexion Pharmaceuticals, Inc. $132 2 payments
  10. Innovative Health Solutions, Inc. $76 1 payment
  11. Other $423 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,764 99 payments
  2. Education $46 5 payments
Products named General payments · program years 2019–2025
  1. STELARA $417 19 payments
  2. Livmarli $329 5 payments
  3. DUPIXENT Immunology $307 16 payments
  4. DUPIXENT Inflammation And Immunology $213 3 payments
  5. GATTEX $196 8 payments
  6. Sucraid $185 10 payments
  7. TREMFYA $159 2 payments
  8. (820) Cholbam $100 7 payments
  9. Cholbam $91 4 payments
  10. ZENPEP $70 3 payments
  11. Other $570 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

104 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record